España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Kezar Life Sciences
KZR
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$6.05
-0.35
-5.47%
At close: -
$6.02
-0.03
-0.50%
After Hours: 5:57 PM EDT
Get Report
Comment
Kezar Life Sciences (KZR) Forecast
News
Earnings
Kezar Life Sciences (KZR) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Kezar Life Sciences (NASDAQ:KZR) Stock
Kezar Life Sciences Stock (NASDAQ: KZR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, December 19, 2024
Wells Fargo Maintains Equal-Weight on Kezar L...
Benzinga Newsdesk
Monday, December 02, 2024
HC Wainwright & Co. Reiterates Neutral on Kez...
Benzinga Newsdesk
Thursday, November 14, 2024
Kezar Life Sciences Received A Letter From Th...
Benzinga Newsdesk
Wells Fargo Maintains Equal-Weight on Kezar L...
Benzinga Newsdesk
Tuesday, November 12, 2024
Kezar Life Sciences Q3 EPS $(2.78) Beats $(3....
Benzinga Newsdesk
Wednesday, October 30, 2024
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
Tuesday, October 29, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Looking Into Kezar Life Sciences's Recent Short Interest
Benzinga Insights
Monday, October 28, 2024
Kezar Life Sciences Announces 1-For-10 Revers...
Benzinga Newsdesk
Friday, October 18, 2024
HC Wainwright & Co. Reiterates Neutral on Kez...
Benzinga Newsdesk
Thursday, October 17, 2024
Penny Stock Kezar Life Sciences Rejects Acquisition Deal From Concentra Biosciences At $1.10/Share, Shelves Mid-Stage Lupus Nephritis Study
Vandana Singh
Kezar Board Unanimously Rejects Unsolicited C...
Benzinga Newsdesk
Kezar Life Sciences Announces IDMC Safety Rev...
Benzinga Newsdesk
Monday, October 14, 2024
HC Wainwright & Co. Reiterates Neutral on Kez...
Benzinga Newsdesk
Thursday, October 10, 2024
Kezar Receives Unsolicited Non-Binding Acquis...
Benzinga Newsdesk
Wednesday, October 09, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Why Saratoga Investment Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, October 08, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Tang Capital Management Submits Non-Binding A...
Benzinga Newsdesk
Tang Capital Management Discloses 9.9% Active...
Benzinga Newsdesk
Monday, October 07, 2024
FDA Put Brakes On Penny Stock Kezar Life Sciences' Mid-Stage Study For Lead Development Candidate After Patient Deaths
Vandana Singh
Friday, October 04, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Wednesday, October 02, 2024
HC Wainwright & Co. Downgrades Kezar Life Sci...
Benzinga Newsdesk
Monday, September 30, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Kezar Life Sciences shares are trading higher...
Benzinga Newsdesk
Kezar Life Sciences Shares Resume Trade
Benzinga Newsdesk
Kezar Life Sciences Reports Voluntarily Cessa...
Benzinga Newsdesk
Trading Halt: Halted at 8:15:00 a.m. ET - Tra...
Benzinga Newsdesk
Wednesday, August 14, 2024
Kezar Life Sciences Discontinues Unpromising Phase 1 Solid Tumor Drug
Vandana Singh
HC Wainwright & Co. Reiterates Buy on Kezar L...
Benzinga Newsdesk
Tuesday, August 13, 2024
Kezar Life Sciences Q2 2024 Adj EPS $(0.30) B...
Benzinga Newsdesk
Monday, July 22, 2024
HC Wainwright & Co. Maintains Buy on Kezar Li...
Benzinga Newsdesk
Friday, May 10, 2024
HC Wainwright & Co. Reiterates Buy on Kezar L...
Benzinga Newsdesk
Thursday, May 09, 2024
Kezar Life Sciences Q1 EPS $(0.30) Beats $(0....
Benzinga Newsdesk
Friday, March 15, 2024
HC Wainwright & Co. Reiterates Buy on Kezar L...
Benzinga Newsdesk
Thursday, March 14, 2024
Kezar Life Sciences Q4 EPS $(0.44) Misses $(0.38) Estimate
Happy Mohamed
Tuesday, February 27, 2024
Reported Late Monday, Everest Medicines And K...
Benzinga Newsdesk
Monday, January 08, 2024
As Oversupply Deflates Lithium Bubble, IPO Market Keeps In High Spirits
Stjepan Kalinic
Monday, December 04, 2023
HC Wainwright & Co. Reiterates Buy on Kezar L...
Benzinga Newsdesk
Monday, November 27, 2023
Analyst Expectations for Kezar Life Sciences's Future
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Kezar L...
Benzinga Newsdesk
Tuesday, November 14, 2023
Wells Fargo Maintains Equal-Weight on Kezar L...
Benzinga Newsdesk
Monday, November 13, 2023
Kezar Life Sciences Q3 EPS $(0.32) Beats $(0....
Benzinga Newsdesk
Friday, November 10, 2023
CEO at Kezar Life Sciences Acquires Company Stock Options Worth 875,000 Shares
Benzinga Insights
Thursday, October 12, 2023
HC Wainwright & Co. Reiterates Buy on Kezar L...
Benzinga Newsdesk
Thursday, October 05, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023
Benzinga Insights
JonesTrading Downgrades Kezar Life Sciences t...
Benzinga Newsdesk
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
